BIOGEN INC. Accounts Payable 2008-2026 | BIIB
Beta
What is accounts payable?
Accounts payable represents money the company owes to suppliers for goods or services received but not yet paid for.
What is BIOGEN INC.'s current accounts payable?
BIOGEN INC. (BIIB) annual accounts payable for 2025 was $432.0M, a 1.84% increase from 2024. BIOGEN INC. accounts payable for the quarter ending March 31, 2026 was $358.5M.
What was BIOGEN INC.'s accounts payable in 2024?
BIOGEN INC. annual accounts payable for 2024 was $424.2M, a 5.18% increase from 2023.
What was BIOGEN INC.'s accounts payable in 2023?
BIOGEN INC. annual accounts payable for 2023 was $403.3M, a 17.95% decline from 2022.
What is BIOGEN INC.'s 5-year accounts payable CAGR?
BIOGEN INC. accounts payable grew at a compound annual growth rate (CAGR) of 1.03% from FY2020 to FY2025, going from $454.9M to $432.0M over 5 years.
Accounts Payable History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-1.0%
FY2020
$454.9M
→
FY2025
$432.0M
080910111213141516171819202122232425
5 years selected
Accounts Payable History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $432.0M | +1.8% | 10-K |
| FY2024 | $424.2M | +5.2% | 10-K |
| FY2023 | $403.3M | -17.9% | 10-K |
| FY2022 | $491.5M | -16.6% | 10-K |
| FY2021 | $589.2M | +29.5% | 10-K |
| FY2020 | $454.9M | -14.3% | 10-K |
| FY2019 | $530.8M | +43.3% | 10-K |
| FY2018 | $370.5M | -6.3% | 10-K |
| FY2017 | $395.5M | +41.4% | 10-K |
| FY2016 | $279.8M | +4.6% | 10-K |
| FY2015 | $267.4M | +16.7% | 10-K |
| FY2014 | $229.2M | +4.2% | 10-K |
| FY2013 | $219.9M | +7.8% | 10-K |
| FY2012 | $204.0M | +9.4% | 10-K |
| FY2011 | $186.4M | +14.7% | 10-K |
| FY2010 | $162.5M | +37.1% | 10-K |
| FY2009 | $118.5M | +10.3% | 10-K |
| FY2008 | $107.4M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →